TY - JOUR A1 - Lorini, Luigi A1 - Bescós Atín, Coro A1 - Thavaraj, Selvam A1 - Müller-Richter, Urs A1 - Alberola Ferranti, Margarita A1 - Pamias Romero, Jorge A1 - Sáez Barba, Manel A1 - de Pablo García-Cuenca, Alba A1 - Braña García, Irene A1 - Bossi, Paolo A1 - Nuciforo, Paolo A1 - Simonetti, Sara T1 - Overview of oral potentially malignant disorders: from risk factors to specific therapies JF - Cancers N2 - Oral squamous cell carcinoma (OSCC) is a very aggressive cancer, representing one of the most common malignancies worldwide. Oral potentially malignant disorders (OPMDs) regroup a variegate set of different histological lesions, characterized by the potential capacity to transform in OSCC. Most of the risk factors associated with OSCC are present also in OPMDs' development; however, the molecular mechanisms and steps of malignant transformation are still unknown. Treatment of OSCC, including surgery, systemic therapy and radiotherapy (alone or in combination), has suffered a dramatic change in last years, especially with the introduction of immunotherapy. However, most cases are diagnosed during the advanced stage of the disease, decreasing drastically the survival rate of the patients. Hence, early diagnosis of premalignant conditions (OPMDs) is a priority in oral cancer, as well as a massive education about risk factors, the understanding of mechanisms involved in malignant progression and the development of specific and more efficient therapies. The aim of this article is to review epidemiological, clinical, morphological and molecular features of OPMDs, with the purpose to lay the foundation for an exhaustive comprehension of these lesions and their ability of malignant transformation and for the development of more effective and personalized treatments. KW - oral potentially malignant disorders KW - risk factors and etiology KW - morphological features KW - molecular alterations KW - treatment Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-242779 SN - 2072-6694 VL - 13 IS - 15 ER -